分子诊断与治疗杂志2024,Vol.16Issue(4) :630-633,638.

联合检测N/OFQ、ApoA1、hs-CRP对冠心病并发SMI的预测价值

Predictive value of joint detection of N/OFQ,ApoA1 and hs-CRP for SMI in coronary heart disease

兰婷 刘兴军 刘国斌 刘峰 赵增 肖波 蒋川 陈丹丹
分子诊断与治疗杂志2024,Vol.16Issue(4) :630-633,638.

联合检测N/OFQ、ApoA1、hs-CRP对冠心病并发SMI的预测价值

Predictive value of joint detection of N/OFQ,ApoA1 and hs-CRP for SMI in coronary heart disease

兰婷 1刘兴军 1刘国斌 1刘峰 1赵增 1肖波 1蒋川 1陈丹丹1
扫码查看

作者信息

  • 1. 金堂县第一人民医院心血管内科,四川,成都 610400
  • 折叠

摘要

目的 探讨联合检测内源性孤啡肽(N/OFQ)、载脂蛋白A1(ApoA1)、超敏C反应蛋白(hs-CRP)对冠心病(CHD)并发无症状心肌缺血(SMI)的预测价值.方法 选取2020年5月2022年12月金堂县第一人民医院心血管内科收治的 156 例冠心病患者,依据是否并发SMI分为并发SMI组(n=65)及无SMI组(n=91),分析影响CHD患者并发SMI的独立危险因素,评估联合检测N/OFQ、ApoA1、hs-CRP对并发SMI的预测价值,并比较不同SMI分型患者血清N/OFQ、ApoA1、hs-CRP水平.结果 两组N/OFQ、ApoA1、hs-CRP、HDL-C、LDL-C比较差异有统计学意义(P<0.05);N/OFQ>6.43 ng/L、ApoA1>120.58 mg/dL、hs-CRP>14.95 mg/L、LDL-C>5.07 mmol/L是CHD患者并发SMI的独立危险因素(P<0.05),而HDL-C>2.96 mmol/L是保护因素(P<0.05);以N/OFQ、ApoA1、hs-CRP构建的CHD并发SMI风险预测模型预测敏感度、特异度、AUC分别为80.00%、83.52%、0.850;心绞痛型、无症状型SMI患者血清N/OFQ、ApoA1、hs-CRP水平均显著低于心肌梗死型SMI患者,差异有统计学意义(P<0.05).结论 血清N/OFQ、ApoA1、hs-CRP水平的监测不仅可对CHD并发SMI早期进行预测,还可为心肌缺血疾病进展评估提供有效依据.

Abstract

Objective To explore the predictive value of joint detection of endogenous nociceptin(N/OFQ),apolipoprotein A1(ApoA1)and hypersensitive C-reactive protein(hs-CRP)for silent myocardial ischemia(SMI)in coronary heart disease(CHD).Methods A total of 156 patients with coronary heart dis-ease who were admitted to the Department of Cardiovascular Medicine at Jintang First People's Hospital from May 2020 to December 2022 were selected.They were divided into two groups based on the presence or absence of SMI:the SMI group(n=65)and the non-SMI group(n=91).The study aimed to analyze the independent risk factors for SMI in patients with CHD and evaluate the predictive value of joint detection of N/OFQ,ApoA1 and hs-CRP for SMI.Additionally,serum levels of N/OFQ,ApoA1 and hs-CRP in patients with different types of SMI were compared.Results There were statistically significant differences in N/OFQ,ApoA1,hs-CRP,HDL-C and LDL-C between the two groups(P<0.05).N/OFQ>6.43 ng/L,ApoA1>120.58 mg/dL,hs-CRP>14.95 mg/L,and LDL-C>5.07 mmol/L were independent risk factors for SMI in patients with CHD(P<0.05),while HDL-C>2.96 mmol/L was a protective factor(P<0.05).The sensitivity,specificity and AUC of the pre-diction model constructed based on N/OFQ,ApoA1 and hs-CRP for predicting SMI were 80.00%,83.52%and 0.850.Serum N/OFQ,ApoA1 and hs-CRP levels in patients with angina pectoris type and asymptomatic SMI were significantly lower than those in patients with myocardial infarction type SMI(P<0.05).Conclusion Monitoring serum levels of N/OFQ,ApoA1 and hs-CRP can not only help predict early SMI in CHD,but also provide an effective basis for evaluating the progression of myocardial ischemia.

关键词

内源性孤啡肽/载脂蛋白A1/超敏C反应蛋白/冠心病/无症状心肌缺血

Key words

Endogenous nociceptin/Apolipoprotein A1/Hypersensitive C-reactive protein/Coro-nary heart disease/Silent myocardial ischemia

引用本文复制引用

基金项目

四川省卫生健康委项目(22PJ061)

出版年

2024
分子诊断与治疗杂志
中山大学

分子诊断与治疗杂志

CSTPCD
影响因子:0.65
ISSN:1674-6929
参考文献量15
段落导航相关论文